Beacon Biotherapeutics is developing a novel transgenic swine for the development of stem cell-based therapies.
Company Details
Company type
Year founded
2019
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Potential end market(s)